Olema Pharmaceuticals (OLMA) Company Statistics | The Fly

Search...

/

Dashboard

Charting

KPIs

Stock Screener

ETF Screener

Earnings Calendar

Events Calendar

Syndicate

Street Research

Portfolios

Alert Settings

© 2026 The Fly Inc.

The Fly Cast

Press play to listen

©

Olema Pharmaceuticals (OLMA) Company Statistics | The Fly

Olema Pharmaceuticals

· OLMA

Dashboard

Financials

Ratios

Valuation

Statistics

747.23 M

+1.17%

General

Market Cap: $747.23M
Enterprise Value: $706.74M
Shares Outstanding: —
Dividend: —
Employees: —
Revenue Per Employee: —

Fundamental Ratios (TTM)

Gross Margin: —
Operating Margin: —
Net Profit Margin: —
FCF Margin: —
ROA: -42.04%
ROE: -48.22%
ROIC: -50.92%
Current Ratio: 8.86
Debt-to-Equity: 0.00
Revenue Per Employee: —

Valuation (TTM)

P/E: —
PEG: —
P/S: —
P/FCF: —
P/B: 1.75
EV/EBITDA: -3.46

Growth

Rev 1Y: —
Rev 1Y Fwd Est: —
Rev 3Y (CAGR): —
Rev 5Y (CAGR): —
Rev 10Y (CAGR): —
EPS 1Y: —
EPS 1Y Fwd Est: —
EPS 3Y (CAGR): —
EPS 5Y (CAGR): —
EPS 10Y (CAGR): —

Income Statement (TTM)

Revenue: —
Gross Margin: —
Operating Expenses: $220.82M
Operating Income: -$221.13M
Net Profit: -$204.57M

Balance Sheet

Cash and Equivalents: $48.6M
Working Capital: $416.86M
Total Assets: $486.58M
Net Debt: -$47.94M
Total Liabilities: $56.01M
Total Equity: $430.56M

Cash Flow Statement (TTM)

Cash Flow from Operations: -$164.74M
Cash Flow from Investing: -$99.54M
Cash Flow from Financing: $260.4M
Free Cash Flow: -$164.74M
Capital Expenditures: $0